Medibank Private Limited

ASX:MPL.AX

3.6 (AUD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q2
Revenue 3,948.74,090.93,785.73,674.43,579.63,618.13,4903,494.43,361.43,4713,329.13,338.83,534.93,470.93,477.23,402.13,405.33,368.53,313.13,267.93,217.8
Cost of Revenue 18000000000-97.10000000000
Gross Profit 3,930.74,090.93,785.73,674.43,579.63,618.13,4903,494.43,361.43,4713,426.23,338.83,534.93,470.93,477.23,402.13,405.33,368.53,313.13,267.93,217.8
Gross Profit Ratio 0.9951111111111.0291111111111
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 0094.893.18776.98971.984.27880.779.592.495.692.788.496.898.399.9121.4108.9
Selling & Marketing Expenses 0072.742.860.825.154.726.760.333.861.638.641.757.14858.143.552.636.94545.4
SG&A 315.8303.7405.5269.3404.8347.2377.4338.8385.7326.6382346.3531.4538.9533.8512.7542.2552.8555.7639599.9
Other Expenses -216.9-167.9-440.4-428.3-549-409.3-405.9-379-497.7-393.240.10000000000
Operating Expenses 315.8167.9440.4428.3549409.3405.9379497.7393.2341.93,064.73,188.83,165.53,153.93,1383,123.13,1743,1113,182.73,086.1
Operating Income 3,632.9496.9396.9241.1245.6312.3312.2323.9197.2256.4342.2274.1346.1305.4323.3259.9282.2217.3193.396.6210.2
Operating Income Ratio 0.920.1210.1050.0660.0690.0860.0890.0930.0590.0740.1030.0820.0980.0880.0930.0760.0830.0650.0580.030.065
Total Other Income Expenses Net -3,413.1493.9396.1332.4244.5311310.9322.4195.6254.6325.900004.20-22.88.8-11.4-78.5
Income Before Tax 219.8493.9396.1332.4244.5311310.9322.4195.6254.6325.9274.1346.1305.4323.3264.1282.2194.5202.185.2131.7
Income Before Tax Ratio 0.0560.1210.1050.090.0680.0860.0890.0920.0580.0730.0980.0820.0980.0880.0930.0780.0830.0580.0610.0260.041
Income Tax Expense 66.6148.7117.298.873.19395.695.558.67695.977.8100.587.891.474.154.65358.325.460.7
Net Income -339.3343.2277.8233.3173.7220.2214.8226.4137.1177.9251196.3245.6217.6231.9190227.6141.5143.859.871
Net Income Ratio -0.0860.0840.0730.0630.0490.0610.0620.0650.0410.0510.0750.0590.0690.0630.0670.0560.0670.0420.0430.0180.022
EPS -0.120.120.10.0850.0630.080.0780.0820.050.0650.0910.0710.0890.0790.0840.0690.0830.0520.0520.0210.026
EPS Diluted -0.120.120.10.0850.0630.080.0780.0820.050.0650.0910.0710.0890.0790.0840.0690.0830.0520.0520.0220.026
EBITDA 40.2-5-1.9-0.91.20.9-1.8-2-1.6-1.8-325.900004.20-22.88.8-11.4-78.5
EBITDA Ratio 0.01-0.001-0.001-000-0.001-0.001-0-0.001-0.09800000.0010-0.0070.003-0.003-0.024